Company
Optiscan Imaging Limited
Headquarters: Mulgrave, VIC, Australia
CEO: Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D.
Market Cap
A$69.3 Million
AUD as of Jan. 1, 2024
US$47.2 Million
Optiscan Imaging Limited Categories
Australia Technology Scientific & Technical InstrumentsAustralia Technology Australia Scientific & Technical Instruments
Top Competitors by Market Capitalization
Industry: Scientific & Technical Instruments
| Company | Market Cap (USD) |
|---|---|
| Keyence | $106.65 B |
| Hexagon AB | $32.17 B |
| Keysight Technologies, Inc. | $26.37 B |
| Fortive Corporation | $25.13 B |
| Garmin Ltd. | $23.75 B |
Detailed Description
Optiscan Imaging Limited develops and commercializes confocal endomicroscopes for clinical and pre-clinical applications in Australia, the United States, China, and Germany. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes designed for translational and pre-clinical research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Optiscan Imaging Limited has the following listings and related stock indices.
Stock: ASX: OIL wb_incandescent